These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 17404599

  • 1. Adiponectin as a negative regulator in obesity-related mammary carcinogenesis.
    Wang Y, Lam KS, Xu A.
    Cell Res; 2007 Apr; 17(4):280-2. PubMed ID: 17404599
    [No Abstract] [Full Text] [Related]

  • 2. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A.
    Cancer Res; 2006 Dec 01; 66(23):11462-70. PubMed ID: 17145894
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
    Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K.
    Circ Res; 2005 Feb 18; 96(3):308-18. PubMed ID: 15662032
    [Abstract] [Full Text] [Related]

  • 10. Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation.
    Bon G, Folgiero V, Bossi G, Felicioni L, Marchetti A, Sacchi A, Falcioni R.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3280-7. PubMed ID: 16740748
    [Abstract] [Full Text] [Related]

  • 11. Effects of adiponectin on breast cancer cell growth and signaling.
    Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP.
    Br J Cancer; 2008 Jan 29; 98(2):370-9. PubMed ID: 18182989
    [Abstract] [Full Text] [Related]

  • 12. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
    Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, Stacey DW.
    BMC Cell Biol; 2006 Aug 30; 7():33. PubMed ID: 16942622
    [Abstract] [Full Text] [Related]

  • 13. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
    Joshi MB, Ivanov D, Philippova M, Erne P, Resink TJ.
    FASEB J; 2007 Oct 30; 21(12):3083-95. PubMed ID: 17485554
    [Abstract] [Full Text] [Related]

  • 14. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
    Yang Y, Ikezoe T, Takeuchi T, Adachi Y, Ohtsuki Y, Koeffler HP, Taguchi H.
    Oncol Rep; 2006 Jun 30; 15(6):1581-90. PubMed ID: 16685399
    [Abstract] [Full Text] [Related]

  • 15. Expression of endothelial nitric oxide synthase is induced by estrogen with glycogen synthase 3beta phosphorylation in MCF-7 cells.
    Nakatani K, Horinouchi J, Yabu Y, Wada H, Nobori T.
    Oncol Rep; 2004 Oct 30; 12(4):833-6. PubMed ID: 15375508
    [Abstract] [Full Text] [Related]

  • 16. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
    Ling Poon S, Lau MT, Hammond GL, Leung PC.
    Endocrinology; 2011 Mar 30; 152(3):764-72. PubMed ID: 21239435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
    Zhang TF, Yu SQ, Guan LS, Wang ZY.
    Anticancer Res; 2003 Mar 30; 23(5A):3575-84. PubMed ID: 14666652
    [Abstract] [Full Text] [Related]

  • 19. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.
    Hepatology; 2002 Dec 30; 36(6):1528-36. PubMed ID: 12447879
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.